Chen was born in Shenzhen, China. He later moved to the United States, where he attended New York University (NYU), studying finance and computer science.[2] During his time at NYU, Chen became involved in blockchain technology, contributing to open-source projects and participating in blockchain-related academic initiatives.[3] From 2017 to 2018, Chen worked as a researcher at Innovating Capital, where his work included blockchain protocol research and trading strategies.[4]
In 2018, Chen co-founded Injective Labs with Albert Chon.[5] The company developed Injective Protocol, a blockchain platform designed for decentralized finance applications, including trading and derivatives.[6][7]
In March 2023, Chen announced the release of the inSVM rollup, the first Solana Sealvel Virtual Machine (SVM) rollup intended for the Solana developer community and Cosmos users.[8][9] In May, Eric Chen helped integrate Pyth with the Injective mainnet.[10]
Injective Protocol is built using the Cosmos SDK and supports various financial products such as spot and derivatives trading.[11][12][13]
In 2024, Forbes included Chen and Albert Chon in its 30 Under 30 Finance list as cofounders of Injective Labs.[14]
Chen has also spoken at a number of conferences, including ETHCC,[15] ETH Denver,[16] Avalanche Summit,[17] Binance Blockchain Week,[18] Permissionless, Messari Mainnet,[19][20] and others.
